Clinical Trial Update: Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Simcyp-guided dosing of simvastatin in patients with liver cirrhosis and portal hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Liver Cirrhosis, Portal Hypertension Related to Cirrhosis | Phase 4 | Status: COMPLETED